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Tom H. Stevens 
 
 
Regulated acidification of intercellular organelles and vesicles is essential for 
many cellular processes, from basic metabolism and protein sorting to synapse function 
and developmental signaling.  These diverse processes are driven by spatiotemporal 
regulation of the V-ATPase, the cellular H+-pump.  In yeast and higher eukaryotes        
V-ATPase localization is directed by the 100-kDa “a” subunit, and many human diseases 
are linked to mutations in “a”.  Saccharomyces cerevisiae contains two “a” isoforms, 
VPH1 and STV1, with all other V-ATPase subunits encoded for by single genes.  The     
V-ATPase contains only one “a” subunit per complex.  Complexes that contain Vph1p 
localize to the vacuole (lysosome), and Stv1p-containing complexes localize to the late 
Golgi/endosome.  Here I present a set of STV1 mutants that are disrupted for Golgi 
retention but not V-ATPase assembly or enzymatic function.  Using a forward genetic 
screen I defined multiple residues within a 39 amino-acid region of Stv1p that are 
necessary for Stv1p retention to the Golgi.  The residues most strongly affecting       
Golgi localization are present in a small STV1-specific insertion of eight residues, 
 v 
suggesting they may bind directly to sorting machinery. However, I also find that 
Stv1p/Vph1p chimeras containing the STV1-specific insertion are not sufficient to direct 
Golgi retention in both minimal (13AA) and expanded (49AA) contexts.  I conclude that 
the Stv1p Golgi retention signal is composed of a complex binding surface, of which the 
central element is a short peptide rich in amino acids with aromatic side chains. 
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CHAPTER I 
AN INTRODUCTION TO PROTIEN SORTING AND THE 
V-ATPASE IN YEAST 
 The budding yeast Saccharomyces cerevisiae is one of the best studied eukaryotic 
model systems, and has proved to be an invaluable model for investigating the molecular 
mechanisms of membrane trafficking.  The intracellular organelles of eukaryotic cells 
contain distinct lipid and protein components necessary for their form and function.  Each 
organelle performs distinct cellular processes and the sorting of proteins to, and between, 
organelles is required both for organelle and protein function.  Many proteins destined for 
organelles or secretion are transported through, or inserted into the membrane of the 
endoplasmic reticulum (ER) (NICCHITTA 2002).  The majority of these ER-localized 
proteins are then packaged into ER-derived membrane vesicles for transport to the Golgi 
apparatus.  While transiting the Golgi many proteins receive post-translational 
modifications before being packaged into Golgi-derived vesicles destined for either the 
plasma membrane or other cellular compartments such as the endosome and/or 
lysosome/vacuole. 
 The yeast vacuole, the functional equivalent of the lysosome in mammalian cells, 
is the most prominent cellular organelle and is easily identifiable by light microscopy.  
The vacuole contains a unique assortment of proteins, and also provides an acidified 
luminal environment of pH ≈ 5.5 (PRESTON et al. 1989).  The vacuole helps to regulate 
cellular homeostasis by affecting osmoregulation, cytosolic ion and pH homeostasis, 
storage of metabolites, removal of toxic substances and macromolecular degradation and 
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recycling (NISHI and FORGAC 2002).  Vacuolar acidification is required to drive many of 
these processes via coupled transport.  
 The Golgi-endosomal membrane network is also acidified in eukaryotic cells as 
diverse as yeast and humans (PERRET et al. 2005).  The acidification of the Golgi-
endosomal network of membranes is important for cells to maintain efficient receptor 
recycling, intracellular targeting of proteins, and many other cellular processes such as 
protein processing and degradation (NISHI and FORGAC 2002). 
 The luminal pH of the Golgi/endosome/vacuole network is generated and 
maintained by the vacuolar-type proton-translocating ATPase (V-ATPase). The V-
ATPase, is formed from two discrete multi-subunit domains; the membrane associated 
H+-translocating Vo domain, and the cytosolic ATP catalytic V1 domain (GRAHAM and 
STEVENS 1999).  These domains are assembled separately and can reversibly associate, 
dependent on cellular conditions (KANE 1995).  The Vo domain is assembled in the ER 
and is transported to the vacuole by vesicle transport via the Golgi/endosome (HILL and 
STEVENS 1994; KAWASAKI-NISHI et al. 2001; MALKUS et al. 2004).  The V1 domain is 
assembled in the cytosol, and assembles with the Vo domain within minutes (PARRA and 
KANE 1998). 
The V-ATPase is one of the smallest know molecular motors that functions by a 
rotational mechanism.  The mechanism is analogous to that of the F1F0 class of ATPases, 
but is reversed with respect to proton flow/ATP catalysis.  i.e. The V-ATPase captures 
energy from the hydrolysis of ATP and uses it to drive protons across the organelle 
membrane, creating an electro-chemical gradient.  The V1 subdomain is comprised of 
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eight subunits termed A-H, and the V0 subdomain is composed of six subunits designated 
a, d, c, c’, c’’, and e.  The V1 is hydrophilic and resides in the cytoplasm, the V0 is 
hydrophobic and spans the lipid bilayer of the resident organelle.  Subunits A and B of V1 
contain the ATP binding and catalytic domains and form a ring-like structure from three 
A-B dimers.  Subunits c, c’, and c’’ of V0 also form a ring structure, most likely 
composed of four copies of c and one copy each of c’ and c’’ (WANG et al. 2007).  The 
V1 and V0 rings are rotationally coupled by V0 subunits D and F and these two rings 
rotate with respect to the stator subunit, designated “a”.  The interface between the V0 
ring and “a” constitutes a “proton pore”, a channel through which protons flow, as a 
result of V1/V0 rotation with respect to “a”.  The remaining subunits either play 
regulatory roles (C and H) or act as a “peripheral stator” (E and G) (TOEI et al. 2010). 
The V- ATPase shares structural homology to the  F1F0 class of ATPases and is 
found in the membranes of all acidified organelles such as the Golgi, endosomes, 
vacuoles, and lysosomes (NISHI and FORGAC 2002).  In higher order eukaryotes the V-
ATPase is dynamically recruited to distinct vesicle populations where it is required for 
complex processes such as neurotransmitter release (DI GIOVANNI et al.), and Wnt signal 
transmission (CRUCIAT et al.).  However these higher order eukaryotes present significant 
experimental difficulties as many of the 14 subunits of the V-ATPase are encoded by 
multiple genes (SUN-WADA et al. 2003), whereas in yeast 13 of the 14 subunits are 
encoded by single genes.  The only V-ATPase subunit encoded by two genes in yeast is 
the 100 kD Vo “a” subunit.  The V-ATPase “a” subunit has 4 isoforms in mammals, and 
each of the four genes is expressed in a tissue-specific manner and their mRNAs are 
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differentially spliced (NISHI and FORGAC 2000; OKA et al. 2001).  Multiple “a” isoform-
specific phenotypes have been recently discovered: V-ATPase “a” subunit “a3” isoform 
has been shown to regulate insulin secretion from pancreatic beta-cells in mouse (SUN-
WADA et al. 2006), and in humans mutations in the “a3” and “a4” isoforms can result in 
osteoporosis (KORNAK et al. 2000; SOBACCHI et al. 2001) and distal renal tubular 
acidosis (SMITH et al. 2000).  The V-ATPase has been shown to regulate pH and cell 
migration in microvascular endothelial cells, a cell type critical for angiogenesis (ROJAS 
et al. 2006). Additionally, RNAi knockdowns of isoforms of “a3” and “a4” have been 
shown to diminish the invasiveness of human tumor cells, indicating that V-ATPase 
localization may act as a positive effector of tumor cell metastasis (HINTON et al. 2009). 
 Although yeast is a simple eukaryote, the V-ATPase complexes localize to 
different compartments depending on which Vo “a” subunit is present in the complex 
(MANOLSON et al. 1994).  This differential localization is of great interest because 
understanding this localization is critical to understanding the physiological functions of 
the various human V-ATPase isoforms (OCHOTNY et al. 2006).  Although loss of 
function mutations affecting the V-ATPase are embryonic lethal in animals, yeast V-
ATPase null mutants (Vma-) are conditionally viable.  Deletion of any of the yeast V-
ATPase subunit genes, or both “a” subunits, results in identical phenotypes: failure to 
acidify the vacuole, sensitivity to elevated extracellular concentrations of Ca2+ and Zn2+, 
and failure to grow above pH 7 (MANOLSON et al. 1994; NELSON and NELSON 1990).  
The two yeast “a” subunit isoforms are encoded by VPH1 and STV1, and both of these 
genes must be deleted to give a Vma- phenotype (MANOLSON et al. 1994).  The Stv1 and 
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Vph1 proteins exhibit 54% amino acid identity, and whereas the Vph1p-containing V-
ATPase localizes to the vacuole membrane (MANOLSON et al. 1992), the Stv1p-
containing V-ATPase localizes to Golgi and endosomal membranes (MANOLSON et al. 
1994) (Figure 1).  Characterization of the mechanism by which the Stv1p V-ATPase is 
retained in the Golgi revealed continual recycling by retrieval from the endosome back to 
the Golgi (KAWASAKI-NISHI et al. 2001). 
 Continual cycling of membrane proteins between the Golgi and endosomes has 
been demonstrated for a number of other yeast proteins, and in some cases a short peptide 
sequence within these proteins has been identified that is required for recycling.  Ste13p 
is retained in the Golgi by one such peptide signal sequence: FXFXD (BRYANT and 
STEVENS 1997; NOTHWEHR et al. 1993).  Although this peptide sequence is present in 
Stv1p, deletion of this motif did not alter the localization of the Stv1p V-ATPase 
(KAWASAKI-NISHI et al. 2001), suggesting that a novel retention signal may be present in 
Stv1p.  Studies using Stv1p-Vph1p chimeras demonstrated that the region of Stv1p 
required for Golgi localization resides is in the N-terminal half of the protein 
(KAWASAKI-NISHI et al. 2001).  Interestingly, these chimeras exhibited enzymatic 
properties dependent on the “a” subunit C-terminal domain but localization dependent on 
the N-terminal domain (LENG et al. 1998).  A number of additional Stv1p-Vph1p 
chimeras and in-frame deletions were constructed in an effort to define more precisely 
the N-terminal region of Stv1p required for Golgi localization.  However, only one of the 
resulting mutants (a deletion removing the FXFXD motif) resulted in a Stv1p V-ATPase 
capable of exiting the endoplasmic reticulum (ER), demonstrating that correct folding of 
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the Stv1p N-terminal domain is required for correct V-ATPase assembly and ER exit 
(KAWASAKI-NISHI et al. 2001). 
 Further insights into the sorting mechanism for the Stv1p-containing V-ATPase 
have come from experiments in yeast that overexpress Stv1p; these cells show 
accumulation of Stv1p V-ATPase on the vacuole (MANOLSON et al. 1994).  Although the 
vacuoles of yeast cells deleted for VPH1 (vph1∆) do not become acidified, vph1∆ cells 
overexpressing Stv1p have acidified vacuoles due to the vacuolar localization of 
missorted Stv1p-containing V-ATPase complexes (MANOLSON et al. 1994) (Figure 2).  
This supports the hypothesis that sorting of the Stv1p V-ATPase is an active process, and 
that this Stv1p V-ATPase complex is retained by a saturable endosome to Golgi retrieval 
mechanism, as is seen for other yeast Golgi membrane proteins (ROBERTS et al. 1992; 
WILCOX et al. 1992). 
In this work we identify mutants of Stv1p that are disrupted for Golgi retention 
but still retain wild-type levels of assembly and enzymatic function.  Furthermore, we 
leverage information about the location of these necessary residues to design and test two 
STV1/VPH1 genetic chimeras containing one or both regions of Stv1p found to be 
necessary for the retention of Stv1p V-ATPase to the Golgi. These chimeras, while fully 
functional, were not retained to the Golgi suggesting that the Stv1p Golgi retention signal 
is comprised of a complex binding surface. 
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CHAPTER II 
IDENTIFICATION OF STV1 MUTANTS THAT ARE DEFECTIVE FOR GOLGI-
RETENTION 
Saccharomyces cerevisiae contains two isoforms of the 100 kilodalton “a” 
subunit, Stv1p and Vph1p.  A single “a” subunit is present per complex, and V-ATPase 
containing Vph1p or Stv1p localize to the vacuole (lysosome in mammals) and Golgi 
respectively.  This lab previously demonstrated that the Golgi targeting information 
resides within the N-terminal 455 residues of Stv1p (KAWASAKI-NISHI et al. 2001).  This 
initial finding was realized by immunolocalization of a functional Stv1p/Vph1p genetic 
chimera that approximately bisected the proteins, swapping the hydrophilic and 
hydrophobic domains of the two “a” isoforms.  Design of this chimera was based on both 
primary amino acid sequence homology and secondary structure predictions, as no high 
resolution structural data existed, or indeed currently exists, for either “a”.  However, 
despite the success of this experiment, dozens of attempts to more precisely define the 
Stv1p Golgi retention signal using genetic chimeras have been unsuccessful (data not 
shown).  The reason for the frequent failure of these chimeric approaches lies in the 
complexity of V-ATPase assembly.  At least five non-subunit proteins participate in V0 
assembly and of those five, three are absolutely essential to the V-ATPase assembly 
process (DAVIS-KAPLAN et al. 2006; GRAHAM and STEVENS 1999; RYAN et al. 2008).  
These assembly factors reside in the ER and function as a “checkpoint” for correct V-
ATPase assembly.  Only V0 deemed to be correctly assembled is allowed to proceed out 
of the ER to transit the biosynthetic pathway.  V0 deemed to be incorrectly assembled 
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fails to exit the ER and the “a” subunit is rapidly degraded.  Many additional chimeras 
made by myself and others failed this stringent quality control check.  As no post-ER 
localization information can be obtained for these assembly-deficient alleles of “a”, these 
chimeras were ultimately uninformative as to the nature of the STV1 Golgi retention 
signal.  Given the difficulties inherent to chimeric approaches I sought to define amino 
acids necessary for correct function of the Stv1p Golgi-targeting signal using a forward 
genetic screen.  Here I describe a set of STV1 mutant alleles disrupted for Golgi retention 
but that still retain wild-type levels of assembly and enzymatic function.  I then used this 
information to create precisely targeted Stv1p/Vph1p chimeras that contain the region of 
Stv1p already defined as necessary.  These minimal Stv1p/Vph1p chimeras exhibited 
wild-type levels of assembly and enzymatic function but were not retained to the Golgi. 
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Figure 1.  Sorting of the yeast V-ATPase 
 
V-ATPase complexes containing the “a” subunit Stv1p localize to the Golgi by 
cycling/recycling from the endosome.  V-ATPase complexes containing “a” subunit 
Vph1p localize to the vacuole. 
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A Genetic Screen Identifies the Stv1p Golgi-Retention Signal 
 
In order to define the Stv1p Golgi-retention signal by forward genetics I required 
a cellular-level growth phenotype that was sensitive to V-ATPase location.  Calcium 
resistance, the most widely used assay for V-ATPase function, is not dependent on V-
ATPase location; cells can acidify either their Golgi or vacuole and still be resistant to 
calcium.  In stark contract to calcium resistance, zinc-resistance has been shown to 
specifically require vacuolar acidification (MANOLSON et al. 1994).  I reasoned that this 
peculiarity of zinc resistance could be leveraged in a genetic screen to couple intercellular 
V-ATPase localization and growth; allowing me to select for mutant alleles of STV1 that 
were disrupted for Stv1p Golgi retention.  Importantly, any identified mutants must retain 
near WT levels of V-ATPase activity in order to be zinc resistant, a condition that 
precludes their having significant defects in V-ATPase assembly or enzymatic function. 
Stv1p V-ATPase resides at steady state within the Golgi complex.  
Overexpression of Stv1p in cells lacking the vacuolar isoform (vph1Δ) causes 
mislocalization of a population of Stv1p V-ATPase to the vacuole, presumably by 
saturation of the Golgi retention machinery (MANOLSON et al. 1994).  I confirmed that 
overexpression of Stv1p caused its mislocalization to the vacuole by expressing an HA-
tagged allele of STV1 from a high copy plasmid in vhp1Δ cells and visualizing Stv1p 
localization by indirect immunofluorescence (Figure 2a).  To confirm that vacuolar-
localized Stv1p V-ATPase is functional I assayed the same strain for cellular zinc 
resistance and observed a large increase in growth compared to the WT control (Figure 
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2b).  Finally, I directly assayed Stv1p-dependent vacuolar acidification using the 
fluorescent dye quinacrine.  Quinacrine can freely traverse membranes in its 
unprotonated form but becomes trapped in acidified compartments in its protonated form, 
causing them to fluoresce.  Quinacrine staining provides direct evidence that vacuolar-
localized Stv1p V-ATPase is enzymatically functional (Figure 2c). 
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Figure 2.  Stv1p V-ATPase Golgi localization is maintained via a saturable retention 
mechanism 
 
A. Wild-type (WT) and vph1∆ were transformed with either a high-copy control plasmid 
(YEp352) or the same plasmid expressing Stv1p from its endogenous promoter (2μ-
STV1).  Strains were grown to exponential phase, serially diluted and spotted on YEPD 
pH5 (pH5) and YEPD (unbuffered) + 1 mM ZnCl2 (Zn2+). B. Indirect 
immunofluorescence microscopy of vph1∆ cells expressing a HA-tagged allele of STV1 
from either the genomic locus (STV1-HA), or from a high-copy (2μ-STV1-HA) plasmid.  
The left panels show differential contrast microscopy (DIC) images and the right panels 
Stv1p as visualized by a fluorophore conjugated antibody stack directed against the HA 
epitope. C. The same strains as in A. stained with quinacrine and concanavalin A-TRITC 
(detailed in materials and methods).  The left panels are differential interference 
microscopy (DIC) images and the right panels show overlayed images of quinacrine in 
green and concanavalin A-TRITC in red. 
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Having confirmed that the mislocalization of Stv1p V-ATPase to the vacuole 
conferred zinc resistance, I reasoned that a targeted mutagenesis of the N-terminal region 
of Stv1p would yield mutant alleles of STV1 which failed to be retained to the Golgi.   As 
vacuolar-localized V-ATPase is sufficient to cause a significant increase in cellular zinc 
resistance, rare mutants that mislocalize Stv1p V-ATPase to the vacuole could be 
selected for on solid media containing zinc chloride.  Furthermore, because growth on 
Zinc-containing media requires a functional V-ATPase, mutations in Stv1p that 
compromised V-ATPase assembly or function would not be isolated.  I considered using 
a GFP-tagged allele of STV1 for our screen, but live cell imaging of Stv1p-GFP displays 
a small amount of vacuole localization in a vhp1Δ background.  A similar distribution is 
not seen by immunofluorescence imaging of an HA-tagged version of STV1.  I suspect 
that the GFP-tagged allele of STV1 is slightly compromised for Golgi retention.  
Additionally, Stv1p-GFP is not fully functional when assayed for calcium resistance.  As 
my screen would be most effective when the initial vacuolar fraction of Stv1p is small in 
comparison to the Golgi-retained fraction we chose the HA-tagged allele for our screen.  
I initially attempted to integrate randomly mutagenized STV1 directly into the genome.  
Unfortunately, in my hands the efficiency of genomic integration was too low to generate 
a sufficiently large library of primary mutants.  Settling for a slightly reduced dynamic 
range of cellular zinc resistance I chose to express the STV1 mutants from a low-copy, 
centromere-based plasmid. 
Full details of the library construction are in the appendix.  Briefly, I randomly 
mutagenized the region of the STV1 gene corresponding to the N-terminal 455 amino 
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acids by mutagenic PCR, with a mutagenesis frequency of approximately 4 nucleotide 
changes per 1000.  These randomly mutagenized fragments were co-transformed with a 
linearized low-copy vector containing the remainder of the STV1 coding sequence and 
native promoter/terminator.  The plasmid was re-circularized by host-mediated 
recombination between the mutagenized fragment of STV1 and the linearized vector.  
Yeast cells that received and recombined both DNA fragments were able to grow on 
media lacking uracil.  The strain background for the recombination was vph1Δ stv1Δ 
making the mutant STV1 the only cellular source of “a” subunit.  That is, only cells that 
correctly accomplished the recombination would be able to grow on media containing 
elevated levels of zinc.  Primary Ura+ transformants were then replica-plated onto media 
containing 5mM ZnCl and the most zinc-resistant isolates were selected for further 
screening.  In order to avoid selection for increases in plasmid copy number I isolated 
zinc resistant mutants from the original -URA plate used for replica printing. 
An improbably large number of zinc-resistant mutants (842) were obtained from 
the primary screen, necessitating the use of a secondary screen (Figure 3a).  Positive 
mutants were isolated from the original -URA plates, re-isolated as single colonies and 
used to inoculate liquid cultures in 96-well format.  Mutant sets were then combined 
using robotics and replica printed in 1536-spot arrays onto both permissive and zinc-
containing media.  Each mutant was represented at sixteen-fold degeneracy, and their 
growth scored relative to control strains present in each array.  The secondary screen 
reduced the number of putative mutants by ~20-fold to a total of 42.  I then attempted to 
test individual mutants for zinc resistance by serial dilution, but discovered small 
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variations between individual colony sizes.  I suspect that these colony size variations 
were due to plasmid copy number fluctuations, and that these fluctuations were 
responsible for the unusually large size of the primary mutant population.  To eliminate 
any false positives due to variation of Stv1p expression I integrated each of the remaining 
42 mutants at the genomic STV1 locus using a “loop-in” integration technique (Figure 3b) 
and re-screened the new library for zinc-resistance. 
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Figure 3.  Isolation of Stv1p mutants disrupted for Golgi-retention 
 
A. A fragment of STV1 was randomly mutagenized by PCR and co-transformed with 
gapped plasmid.  The fragments were re-circularized by homologous recombination in 
vph1Δ stv1Δ yeast and plasmid-containing colonies were screened by replica plating and 
robotic arrays on media containing zinc.  Zinc resistance is indicative of vacuolar-
localized Stv1p V-ATPase. B. Following the screens depicted in part A, mutants were 
integrated into vph1Δ stv1-NTΔ cells, restoring the STV1 genomic locus and stabilizing 
Stv1p expression levels. 
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Following integration (the tertiary screen) 24 mutants displayed elevated zinc 
resistance when compared to controls and of those 24, 13 were scored as having a 
medium to strong zinc resistance phenotype.  Further characterization was performed on 
this most phenotypically strong subset of 13 mutants.  Examples and a summary of the 
growth data is shown in Figure 4.   To determine if the mutants contained bona fide 
disruptions to their Golgi-retention signals I performed the experiments shown in Figure 
5.  First, I wished to know if the increased zinc resistance of the mutants was due to the 
mislocalization of the Stv1p V-ATPase to the vacuole.  The integrated Stv1p mutants 
contained a triple hemagglutinin (HA) tag inserted after amino acid Leu227, an allele of 
Stv1p shown to be Golgi-localized and fully functional by this lab (KAWASAKI-NISHI et 
al. 2001), a finding that we reconfirmed (data not shown).  Using anti-HA antibodies I 
visualized Stv1p by indirect immunofluorescence and observed staining of the vacuolar 
limiting membrane in mutant, but not control cells.  I then used quinacrine staining to 
demonstrate an increased vacuolar acidification in the mutants.  Lastly, as increased 
expression of Stv1p can lead to its mislocalization, I assayed mutant levels of Stv1p by 
Western blot and observed no difference between Stv1p expression levels and the non-
mutant control.  These data show that the Golgi retention signal of Stv1p is disrupted in 
the randomly isolated mutants, and upon disruption of this signal the Stv1p-containing V-
ATPase is mislocalized to and acidifies the vacuole. 
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Figure 4.  Mutant analysis identified the STV1 residues (50) Phe and (83) Trp-Lys-
Tyr as necessary for retention of the Stv1p V-ATPase to the Golgi/endosomal 
network 
 
A. Wild-type (WT), and vph1∆ containing either integrated wild-type STV1 (vph1∆) or 
integrated mutant STV1 (STV1*, and mutant designation) were serially diluted (5-fold 
dilutions) and spotted onto permissive media (YEPD) or YEPD containing 1 mM ZnCl2. 
B. Schematic depicting randomly isolated mutations.  The red-shaded area indicates the 
region of Stv1p subjected to random mutagenesis.  Below, the expanded region from 
amino acid 40 to 95 highlights amino acid change(s) found in individual zinc-resistant 
mutants. 
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Figure 5.  Mutant Stv1p V-ATPase is mislocalized to, and acidifies the vacuole.  
Mislocalization is not due to overexpression 
 
A. vph1Δ cells containing either unmutagenized STV1 (STV1-HA) or mutant STV1 
(STV1*-HA and mutant designation) that contain three copies of a hemagglutinin epitope 
tag (HA) were visualized by indirect immunofluorescence (α-HA) as described in the 
appendix, and Normarski optics (DIC).  The vacuole is identifiable in the DIC image as a 
large indentation. B.  DIC images (left) and overlayed fluorescent images (right) of the 
same strains in part A, quinacrine staining is shown as green (Quinacrine accumulates in 
acidified compartments), and the red staining is conA-TRITC which stains the cell wall. 
C. Western blot of the same strains from Part A.  Top panel shows steady-state protein 
levels of Stv1p-HA in60 μg of whole-cell extract using α-HA antibodies and the bottom 
panel shows protein levels of Dpm1p, used as a loading control.   
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I sequenced the STV1 coding sequence and promoter for all 42 mutants from the 
secondary screen at 3x coverage using traditional high-fidelity sequencing.  The 
sequencing was completed before the results of the tertiary (integration) screen were 
known.  As only 13 of these 42 were ultimately confirmed as Stv1-mislocalizers I used 
the full sequence dataset to eliminate mutations common to both the mutant and non-
mutant sets.  The full list of amino acid changes and zinc resistances for individual 
mutants is shown in Table 1 (see the Appendix for this table).  I also noted that nucleotide 
changes of ~5/kb were found in the mutant and non-mutant pool and appeared to be 
evenly spread throughout the targeted (bp 1-1266) region of STV1 (data not shown). 
Interestingly, while many mutants contained multiple amino acid substitutions, 
upon comparison of mutant sequences by multiple sequence alignment I found that 
residue changes were clustered in two small regions (Figure 4b).  The first, Trp83-Lys-Tyr 
lies in a 13 AA region unique to Stv1p.  The second, Phe50 is conserved between Stv1p 
and Vph1p.  I tested the necessity of these amino acids for Stv1p Golgi-retention by 
changing individual residues in and around these regions to alanine.  Starting with the 
genomic integration vector containing the wild-type STV1 sequence, I introduced 
nucleotide changes using site-directed mutagenesis.  Introduced nucleotide changes were 
confirmed by sequencing of a ~600bp region surrounding the introduced mutation(s).  
These new STV1 mutations were then integrated at the native STV1 locus using the same 
integration method used for the randomly isolated mutants. 
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Trp83-Lys-Tyr Is Required for Efficient Retention of Stv1p V-ATPase to the Golgi. 
 
One region of Stv1p, Trp83-Lys-Tyr (W83KY), contained residues that when 
mutated singly or in combination produced a comparatively large increase in zinc-
resistance;  increases that equaled or exceeded the phenotype of the randomly isolated 
mutants (Figure 6a, and data not shown).  This observation was intriguing because 
residues 83 to 91 comprise a Stv1p-specific insertion not present in Vph1p (Figure 6b), 
and as such may comprise an interaction surface between the V-ATPase and Golgi 
retention machinery.  The residues that when mutated individually produced the largest 
increase in cellular zinc resistance were the aromatic residues Trp83 and Tyr85 (Figure 6a).  
This result also peaked my curiosity as aromatic residues are often found to directly 
mediate protein-protein interactions between sorting factors and cargo.  In order to more 
thoroughly characterize this region I performed an alanine scan of residues 81 to 91.  
Results of the alanine scan show that residues flanking W83KY have a comparatively 
small effect on zinc-resistance and that residues Trp83 and Tyr85 are the most critical for 
Stv1p Golgi-retention (Figure 7). 
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Figure 6.  Single and multiple amino acids necessary for Golgi-targeting of the Stv1p 
V-ATPase 
 
A. 5-fold serial dilutions of vph1Δ containing either integrated wild-type STV1 or the 
indicated mutations, spotted onto either permissive media (YEPD) or YEPD containing 
1.0 mM zinc chloride. B. Protein sequence alignment of Stv1p and Vph1p, black arrows 
depict the amino acids changed to alanine in the mutants in Part A. 
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Figure 7.  Summary of the residue changes made in the Phe50 to Trp83-Lys-Tyr 
region of Stv1p 
 
Expanded view of Stv1p with the alignment to Vph1p shown in Figure 6.  Bars above 
and below the horizontal line show the relative zinc-resistance compared to Wild Type in 
arbitrary units (5.0 corresponds to the zinc-resistant mutant).  Conservative replacements 
at Stv1p positions 83 and 85 are discussed in the text, conservative changes elsewhere 
indicate that the Stv1p residue was changed to the corresponding Vph1p residue.  Colors 
indicate combinatorial mutants (except for red bars that lie below the horizontal line). 
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In order to confirm that mutations in Trp83-Lys-Tyr result in mislocalization of 
Stv1p V-ATPase to the vacuole, without increasing steady-state levels of Stv1p, I 
performed the experiments discussed below.  Cells expressing mutant Stv1p with the 
residues changes Trp83 -> Ala83 and Tyr85 -> Ala85, present either singly (W83A and 
Y85A) or in combination (83AKA), display a vacuolar staining pattern by indirect 
immunofluorescence, while the unmutagenized control cells do not (Figure 8a - left 
panels, and Data not shown).  Furthermore, vacuoles in the mutant cells accumulate 
quinacrine, demonstrating that their vacuoles are acidified (Figure 8A – right panels and 
Data not shown).  Finally, the vacuolar localization of Stv1p in mutant cells is not due to 
overexpression of the mutant Stv1p as demonstrated by semi-quantitative Western blot 
(Figure 8b).  Taken together these data indicate that replacement of the aromatic residues 
at positions 83 and 85 of Stv1p with alanine disrupt the Golgi-retention signal causing the 
mutant Stv1p V-ATPase to localize to and acidify the vacuole.  More biochemically 
conservative substitutions were also made at positions 83 and 85:  Trp83 was changed to 
both phenylalanine and tyrosine and Tyr85 was changed to phenylalanine in order to 
retain hydrophobic/aromatic character similar to that found in the wild-type residues.  
These conservative replacements caused a significant increase in zinc resistance, 
although the phenotypes were not as strong as those seen for the alanine changes (Figure 
7). 
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Figure 8.  Disruption of Trp83, Tyr85 results in mislocalization of Stv1p V-ATPase to 
the vacuole, and vacuolar acidification.  Mislocalization is not due to overexpression 
of Stv1p 
 
A. DIC and indirect immunofluorescence staining of vph1Δ cells containing integrated 
wild-type STV1 (STV1-HA) or STV1 with residues Trp83 and Tyr85 changed to alanine 
(left panels).  Quinacrine staining and DIC images of the same strains (right panels). B. 
Western blot of the indicated strains using α-HA antibody (Stv1p) and α-Dpm1 (Loading 
Control).  The faint band seen in the stv1Δ lane is due to cross-contamination from the 
WT lane. 
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Analysis of the mutant sequence data also indicated that mutations at position 
Phe50 of Stv1p disrupt the Golgi-retention signal (Figure 4b).  In order to test this 
prediction I used site-directed mutagenesis to change Phe50 to alanine (F50A) and found 
that this mutant displayed a moderately strong zinc-resistance phenotype (Figure 6a).  
Secondary structure predictions indicate that an alpha-helical region may lie between 
residues 50 and 83 of Stv1p.  If so, the F50A mutation may alter the conformation of this 
helix and cause Stv1p mislocalization by an indirect disruption of the 83WKY motif.  
One prediction of this hypothesis is that 83AKA should be epistatic to F50A with respect 
to zinc resistance.  In order to test this I combined the two mutants, making the double 
mutant: F50A, 83AKA.  If the F50A phenotype is due solely to an indirect disruption of 
83WKY (making it 83AKA-like) I would expect the zinc resistance of the double mutant 
(F50A, 83AKA) to equal that of 83AKA, however the double mutant was more zinc 
resistant than either of the single mutants (Figure 6a).  This finding is remarkable, and 
indicates that the Stv1p Golgi-retention signal is not comprised of just a canonical sorting 
motif.  As outlined above, discrete sorting signals are often able to direct the Golgi 
retention of other proteins.  These signals are modular, in that they can be appended to 
proteins that normally localize to terminal sorting destinations (i.e. secretion) and cause 
the Golgi retention of the chimeric protein.  Such modularity indicates that these sorting 
motifs fold correctly and are identified and acted upon by their cognate sorting 
machinery.  My finding that regions of Stv1p located 40 amino acids apart independently 
act to direct the Golgi localization of Stv1p indicates that the V-ATPase interface with 
the Golgi retention machinery is more complex than was first assumed. 
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Stv1p/Vph1p Chimeras Containing the Residues Necessary for Stv1p Golgi-
Retention Fail to Localize to the Golgi 
 
The residues I defined as necessary for retention of the Stv1p V-ATPase to the 
Golgi lie between amino acids Phe50 and His88.  As shown in Figure 6b, Phe50 is 
conserved between Stv1p and Vph1p and as such is unlikely to bind directly to Golgi-
retention factor(s).  The Phe50 to His78 region is fairly well conserved between the “a” 
isoforms suggesting that these regions may form similar secondary structures in Stv1p 
and Vph1p.  As residues 83 to 91 of Stv1p exist in a Stv1p-specific insertion I reasoned 
that moving these residues from Stv1p to the same context in Vph1p would cause Golgi-
retention of the chimeric protein.  The chimeric protein was integrated at the STV1 locus 
under control of the STV1 promoter, and is expressed at similar levels to native Stv1p 
(data not shown).  To design this chimera I used the sequence alignment of Stv1p and 
Vph1p in order to identify conserved regions flanking the Stv1p-specific insertion 
(Figure 9b).  Using this information and secondary structure predictions I chose to 
replace the five amino acids, 80 to 84 of Vph1p with amino acids 83 to 91 of Stv1p 
(Figure 9c).  This 13 amino acid Stv1p-Vph1p chimera is hereafter referred to as 
“L1/R1”. 
The L1/R1 Stv1p-Vph1p chimera displays full enzymatic function when assayed 
by cellular resistance to calcium (Figure 9a).  If L1/R1 is retained to the Golgi less V-
ATPase would be present on the vacuole causing a decrease in cellular zinc resistance.  
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However, L1/R1 displays identical zinc resistance compared to controls (Figure 9a), and 
by immunolocalization L1/R1 appears to be exclusively on the vacuole (Figure 9b). 
I also constructed a STV1/VPH1 genetic chimera containing the entire Phe50 to 
His78 region.  This chimera contained 49 amino acids from Stv1p in place of 41 amino 
acids of Vph1p and is detailed in Figure 9c.  This chimeric construct, designated 
“L2/R1”,  was fully functional but also failed to localize to the Golgi when measured by 
the same assays as used for L1/R1 (Figure 9a and b). 
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Figure 9.  The Trp83-Lys-Tyr region of Stv1p is not sufficient to cause Vph1p to be 
retained to the Golgi 
 
A. 5-fold serial dilutions of wild-type (WT) stv1Δ vph1Δ, VPH1 integrated at the STV1 
genomic locus (with STV1 promoter), and the STV1-VPH1 chimeras L1/R1 and L2/R1 
integrated at the STV1 genomic locus. B. The same strains as in Part A assayed by 
indirect immunofluorescence using α-HA antibody (VPH1 and both chimeras have a 
3xHA tag at their C-terminus) and DIC imaging. C. Schematic showing the regions of 
STV1 moved to VPH1, and the residues of VPH1 that were removed to create the L1/R1 
and L2/R1 STV1-VPH1 genetic chimeras. 
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CHAPTER III 
 
DISCUSSION 
 
This project aimed to more thoroughly characterize the signal in Stv1p that causes 
retention of the Stv1p V-ATPase to the late Golgi compartment.  Previous work indicated 
that Stv1p is maintained at steady-state in the Golgi, at least in part, by retrograde 
transport from the endosome to the Golgi.  This retrograde component of the Stv1p 
sorting process was discovered by co-localizing Stv1p with endosomal marker proteins in 
a class “E” vps mutant background.  In a class “E” vps mutant, proteins that normally 
traffic to the endosomal network do so normally but fail to exit, due to a specific block in 
endosomal retrograde and anterograde traffic.  This phenotype of the class “E” mutants 
effectively turns the endosome into a sorting “black hole”;  proteins that transit the 
endosome, even briefly, become trapped in an abnormally large endosome termed the 
class “E” compartment.  In wild type cells Stv1p localizes to the late Golgi but in class 
“E” mutants its localization is shifted to the class “E” compartment, indicating that the 
endosome is part of Stv1p’s normal sorting itinerary.  Since Stv1p does not co-localize 
with endosomal markers in wild-type cells at steady-state, it must only reside in the 
endosome for a relatively brief period of time before being returned to the late Golgi via 
retrograde transport.  This type of Golgi-endosome sorting “loop” has been shown to 
direct the correct localization of other late Golgi proteins, such as Ste13p and Vps10p 
(BRYANT and STEVENS 1997; COOPER and STEVENS 1996).  The signals in Ste13p and 
Vps10p that direct their retrieval from the endosome to the Golgi have been well 
characterized, and both signals contain aromatic residues critical for their function.  
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Additionally, Ste13p has been shown to contain a second sorting signal, one that delays 
exit of the protein from the late Golgi (BRYANT and STEVENS 1997).  As stated above it 
appears certain that Stv1p is retained to the Golgi by retrograde-mediated retrieval from 
the endosome, but a Golgi-retention signal similar to that characterized for Ste13p may 
also play a role.  My finding that aromatic residues are the most crucial for Stv1p Golgi 
localization supports the notion that I have identified a signal directing endosome to 
Golgi retrograde transport. 
In order to isolate mutant alleles of Stv1p that failed to localize Stv1p V-ATPase 
to the Golgi I performed a forward genetic screen using cellular zinc resistance as a 
readout for V-ATPase localization.  Cellular zinc resistance requires vacuolar 
acidification.  Therefore, mutant alleles of Stv1p that are defective for Golgi-retention 
(i.e. vacuolar localized) must also retain near wild type levels of V-ATPase assembly and 
enzymatic function.  The region of STV1 corresponding to the N-terminal 455 amino 
acids was mutagenized, as this region was shown to contain the Golgi-retention signal 
(KAWASAKI-NISHI et al. 2001).  The initial screen was performed with the mutant STV1 
gene on a low-copy (CEN) based plasmid containing the native STV1 promoter and 
terminator sequences.  The mutant STV1 was the only cellular source of “a” subunit.  
This experimental design resulted in some complications;  when plasmids were rescued 
from mutant cells and retransformed into an isogenic strain the plasmid did not always 
yield a zinc resistance phenotype.  Additionally, I noticed fluctuations in individual 
colony size when testing the mutants for zinc resistance by serial dilution.  I believe that 
these effects were due to plasmid copy-number fluctuations, because vph1Δ stv1Δ 
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containing plasmid born STV1 gains a selective growth advantage when Stv1p expression 
is increased.  I avoided a severe selection for increased Stv1p expression by never 
maintaining cells following zinc exposure, but in my hands, increased expression of 
Stv1p results in a slight increase to fitness on non-selective media as well.  This 
variability caused a multitude of problems during the nascent stages of the project and I 
ultimately decided to integrate the most zinc resistant alleles of STV1 into the endogenous 
genomic locus.  Genomic integration of STV1 completely stabilized the zinc resistance 
phenotype but had the unexpected effect of significantly reducing the size of the mutant 
pool.  However, I now had mutants that behaved reproducibly and clearly mislocalized 
Stv1p V-ATPase to the vacuole by a variety of assays.  Each of these randomly isolated 
mutants, and the mutants I later created, have been fully sequenced twice and then 
individually integrated and tested for zinc resistance a minimum of four times.  The 
phenotypes are completely stable and are due solely to the individual residue changes 
found in each mutant. 
Sequence analysis of the randomly isolated mutants was used to identify regions 
of the Stv1p peptide that might be required for Stv1p V-ATPase Golgi retention.  Dozens 
of regions tested, but only when Tyr85-Ile-Leu-His and Phe50 were changed to alanine 
were the resulting mutants significantly zinc resistant.  Further analysis defined Trp83 and 
Tyr85 as the residues most critical for Stv1p Golgi retention.  These results are almost 
completely consistent with the primary sequence data, as 11 of 13 of the most zinc 
resistant mutants have residue changes in these areas.  Of the two outliers, one contains a 
leucine to proline at position 43 and may affect Phe50, and the second contains an alanine 
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to proline substitution at position 79, which would almost certainly affect the 
conformation of the Trp83-Lys-Tyr region.  The most phenotypically severe mutant I 
created was Phe50 Ala83-Lys-Ala, although this mutant appears to mislocalize only 
slightly more Stv1p than Ala83-Lys-Ala alone. Trp83-Lys-Tyr lies in a Stv1p-specific 
region not found in Vph1p by sequence alignment, making it a good candidate for the 
region of Stv1p that binds directly to the endosomal sorting machinery.  Because of this, I 
choose to focus my efforts on this region and performed an alanine scan to define the 
relative contribution of its constituent amino acids to Stv1p Golgi retention.  I also 
defined the flanks of this important region where amino acid substitutions no longer 
affected Stv1p localization. 
As described above, aromatic amino acids in small regions of three to five 
residues frequently mediate binding of cargo proteins to the endosomal sorting 
machinery, such as the retromer complex.  My discovery that the tryptophan and tyrosine 
residues in the Trp83-Lys-Tyr motif of Stv1p are required for its Golgi retention indicates 
that Stv1p may bind to the endosomal sorting machinery in a canonical fashion.  Phe50 
also plays a role in Stv1p sorting, albeit a significantly smaller one than Trp83-Lys-Tyr.  
Unlike Trp83-Lys-Tyr, Phe50 is conserved between Stv1p and Vph1p, and is therefore 
unlikely to directly bind to sorting machinery.  Secondary structure prediction algorithms 
indicate that an alpha helix may lie between Phe50 and Trp83-Lys-Tyr, and that the 
substitution Phe50 -> Ala50 would act as a “helix-breaker”.  If these predictions are correct 
Ala50 may affect the Golgi localization of Stv1p via an indirect perturbation to the Trp83-
Lys-Tyr motif.  However, the fact that the Ala50, Ala83-Lys-Ala double mutant is slightly 
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more zinc-resistant than Ala83-Lys-Ala alone indicates that Trp83 and Tyr85 is unlikely to 
be the only point of contact with the Golgi-retention machinery, and that Phe50 may play 
a direct role along with Trp83-Lys-Tyr in binding to a single sorting complex.  An 
intriguing possibility is that Phe50 may mediate a second sorting process, such as 
delaying V-ATPase exit from the Golgi in a mechanism similar to that described for 
Ste13p (BRYANT and STEVENS 1997). 
Having demonstrated the necessity of the Trp83-Lys-Tyr residues for Stv1p Golgi 
retention, I wished to address whether these residues were sufficient to cause Vph1p’s 
retention to the Golgi.  The Trp83-Lys-Tyr residues lie in a Stv1p-specific insertion, and I 
was hopeful that if this region was introduced into Vph1p it would cause the chimeric 
protein to localize to the Golgi.  I created a total of six Stv1p/Vph1 chimeras, and all 
were placed under the expression of the low-level STV1 promoter to avoid 
overexpression.  Three of them were not assembly competent, and a fourth was 
minimally functional (data not shown).  Two chimeras were functional, one contained the 
Stv1p-specific insertion, and the second contained the entire Phe50 to Ala83-Lys-Ala 
region.  Neither of these chimeras displayed Golgi localization, residing instead on the 
vacuolar membrane.  There are many possible reasons why the residues I defined as 
necessary are not sufficient to cause Vph1p’s retention to the Golgi.  Judging from low 
resolution cryo-electron microscopy data, the N-terminus of the “a” subunit appears to 
physically interact with at least four V-ATPase subunits (H, E, G and d) (ZHANG et al. 
2008).  In addition, the N-terminus of “a” is predicted to self-interact, making the Trp83-
Lys-Tyr region proximal to a region of the Stv1p at approximately residue 350.  If Stv1p 
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interacts with itself in that region, it may be that this self interaction is required for proper 
presentation of the sorting motif.  My data clearly highlights the complexity of the Stv1p 
Golgi-retention signal, and I believe that future studies and higher resolution structural 
information will ultimately determine whether Trp83-Lys-Tyr directly binds to endosomal 
sorting factors. 
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APPENDIX 
 
MATERIALS AND METHODS 
 
 Strains-Strains were propagated and transformations were done as in Burke et. al 
2000 (BURKE et al. 2000). 
 
 Gene knockouts-Genomic deletions were obtained by PCR amplification of the 
NAT or KAN cassette (GOLDSTEIN and MCCUSKER 1999) with PCR primers containing 
additional sequence that was homologous to the desired integration site.  These linear 
DNA fragments were transformed into cells, and drug-resistant integrants were selected 
on solid media.  Drug-resistant isolates were assayed for correct integration of the drug 
cassette by diagnostic PCR. 
 
 STV1 random mutant construction-A CEN-based vector (pRS316) containing the 
full-length STV1 (3xHA at AA position 227) and 500 bp of STV1 5’ UTR and 135 bp of 
3’ UTR was constructed and then modified by Quick-change PCR to include two unique 
restriction sites:  NheI 74 bp 5’ to the STV1 start codon, SnaBI (silent) 1,403 bp 3’ to the 
STV1 codon.  The STV1 plasmid was then linearized with the NheI and SnaBI restriction 
endonucleases, and co-transformed into vph1Δ stv1Δ yeast with a randomly mutagenized 
(Genemorph II; Stratagene) fragment of STV1 containing 40 bp overlaps.  The plasmid 
was re-circularized in yeast and the resulting mutants screened for zinc resistance.  To 
integrate the mutants into the genome the same NheI/SnaBI was cloned by in vitro 
ligation into a second vector that lacked the ability to replicate in yeast (pRS306).  The 
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pRS306 recipient vector contained a 3’ 642 bp truncation of the STV1 ORF and also 
contained a unique MluI restriction site (silent) at basepair 1,836.  Once the mutagenized 
fragment had been transferred to the pRS306 “suicide vector” it was linearized by digest 
with MluI and transformed into vph1Δ::NAT stv1-NTΔ::KAN cells.  Correct “loop-in” 
integration restored a functional copy of STV1 making the cells both Ura+ and calcium 
resistant. 
 
 STV1 random mutant screening-vph1Δ stv1Δ cells containing plasmid-borne 
mutant STV1 were screened by replica plating onto YEPD media containing 5 mM ZnCl2.  
The plasmid-borne mutants were then screened by printing at 16-fold degeneracy using a 
RoToR HDA robot (Singer Instruments) onto YEPD + 4 mM  ZnCl2.  The levels of zinc 
were high relative to the concentration used for spot testing of the integrants because of 
plasmid-mediated increases in Stv1p expression.  I also observed that high cell densities 
displayed a reduced zinc sensitivity. 
 
 STV1 mutant construction-Mutations were introduced de novo into STV1 by 
Quick-change PCR mutagenesis directly into the pRS306 suicide vector.  Resulting 
mutations were confirmed by sequencing, and integrated as described for the randomly 
isolated mutants. 
 
 STV1/VPH1 chimera construction-The VPH1 coding sequence was PCR 
amplified with tailed primers and in vivo ligation between homologous sequences in that 
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linear fragment and a linearized STV1 plasmid produced a CEN based plasmid with STV1 
5’ and 3’ UTR flanking the VPH1 ORF.  A 3xHA tag/alcohol dehydrogenase 
terminator/NAT drug resistance cassette was then added 3’ to the VPH1 stop codon by in 
vivo ligation.  A unique restriction site was added to the VPH1 ORF at the region where 
L1/R1 from STV1 was to be appended and L1/R1 and other STV1 fragments were 
introduced by in vivo homologous recombination between this linearized plasmid and a 
STV1 PCR fragment (L1/R1, L2/R1, etc.) containing primer tails that served to target the 
recombination events. 
 
 Culture conditions -Yeast were cultured in YEPD (1% yeast extract, 2% peptone, 
and 2% dextrose), YEPD buffered to pH 5.0 using 50 mM succinate/phosphate. Growth 
tests were performed by culturing exponentially growing yeast in rich medium to a cell 
density of 1.0 OD600, serially diluted fivefold, and spotted onto agar plates. Plates used 
included YEPD pH 5.0, or YEPD plus the indicated amount of ZnCl2. 
 
Whole cell extract preparation and immunoblotting-Whole cell extracts were prepared as 
previously described (RYAN et al. 2008). Briefly, cultures were grown overnight in SD 
dropout media and then diluted to 0.25 OD600/ml in YEPD pH 5.0 and grown to a cell 
density of OD600 = 1.0. A total of 10 OD600 of the culture was centrifuged, resuspended in 
0.25 ml Thorner buffer (8 m urea, 5% SDS, and 50 mM TRIS pH 6.8), and vortexed with 
0.2 ml of glass beads. Following centrifugation, protein concentrations were determined 
using a modified Lowry protein assay (MARKWELL et al. 1978). Equal amounts of protein 
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were separated by SDS–PAGE, transferred to nitrocellulose membrane, and probed with 
antibodies. Antibodies used included monoclonal primary anti-HA (12CA.5.16.4; 
Invitrogen), anti-Dpm1p (5C5; Invitrogen), and secondary horseradish peroxidase-
conjugated antimouse antibody (Jackson ImmunoResearch Laboratories, West Grove, 
PA). Blots were visualized by ECL detection. 
 
Quinacrine microscopy-Yeast were stained with quinacrine as previously described 
(FLANNERY et al. 2004). Briefly, cells were grown overnight in YEPD pH 5.0 plus 
adenine, and diluted to a cell density of 0.25 OD600/ml in YEPD. Yeast were harvested 
at a density of 0.8–1.0 OD600/ml and 1ml of culture was placed on ice for 5 min. Cells 
were pelleted and resuspended in 200 mm quinacrine, 100 mm HEPES pH 7.6, and 50 
mg/ml of concanavalin A tetramethylrhodamine (Invitrogen) in YEPD for 10 min at 30°. 
Following staining with quinacrine, cells were placed on ice and washed three times in 
100 mm Hepes pH 7.6 plus 2% glucose (4°). Microscopy images were obtained using an 
Axioplan 2 fluorescence microscope (Carl Zeiss, Thornwood, NY). A 3100 objective was 
used as well as AxioVision software (Carl Zeiss). 
 
Immunofluorescence microscopy-Yeast were fixed and stained as previously described 
(KAWASAKI-NISHI et al. 2001) with the following modifications:  The primary antibody 
was changed to a mouse monoclonal α-HA.11 (16B12; Covance) diluted 1:250 and 
incubated with fixed cells overnight at 4°.  The secondary antibody was goat α-mouse 
conjugated to Alexa-488 (Invitrogen) used at a 1:500 dilution. Microscopy images were 
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obtained using an Axioplan 2 fluorescence microscope (Carl Zeiss, Thornwood, NY). A 
3100 objective was used as well as AxioVision software (Carl Zeiss). 
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Table 1-Summary of randomly isolated mutant amino acid changes and zinc 
resistance 
 
Mutant #            Growth Amino Acid Changes 
9  +++ Q98H, K299R, K310N, H351R, K362N, Q379K 
25  ++ E127V, A168T, L314Q, H344Y, H351Q 
31  ++ A49G, L87S, R246K, N268Y, V312F 
57  + L43P, K121R 
79  ++ N72I, N117S, I329M, N415D 
89  +++ D205V, D401Y, N415D 
95  + A49V, K362N, Q379R, I393V 
99  ++ I86N, D212G 
101  +++ H88L, I193S, Q209H, V303A, D337Y, I417N 
104/249 ++ L47S, D146Y, Q379R 
132  +++ E76V, A79P, N164D, E340D, Q341K, H344Y, I403V 
146  ++ I86F      
155  +++ F50L, Q152L, F203L, L259S, E409D 
172  ++ R59G, L218I, N415D 
176  +++ T124S, T219A, I417N 
187  +++ A49T, R60S, W83R, Q132H, V163I, H236N, L296M, T338A 
200  ++ N117S, Q152L, L276M, F414S 
213  + N56T, P110H, I176V, L307I, N372D, N415D 
254  ++ L47S, D146Y, Q379R 
270  ++ H88L, Q150L, W257L, I304L, T324A 
301 +++ D46E, F50L, S198R, D217V, Y238F, K298E, T345A,T405M 
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